Cosmetics are widely used by people around the world to protect the skin from external stimuli. Consumer preference towards natural cosmetic products has increased as the synthetic cosmetic products caused adverse side effects and resulted in low absorption rate due to the chemicals’ larger molecular size. The cosmetic industry uses the term “cosmeceutical”, referring to a cosmetic product that is claimed to have medicinal or drug-like benefits. Marine algae have gained tremendous attention in cosmeceuticals. They are one of the richest marine resources considered safe and possessed negligible cytotoxicity effects on humans. Marine algae are rich in bioactive substances that have shown to exhibit strong benefits to the skin, particularly in overcoming rashes, pigmentation, aging, and cancer. The current review provides a detailed survey of the literature on cosmeceutical potentials and applications of algae as skin whitening, anti-aging, anticancer, antioxidant, anti-inflammation, and antimicrobial agents. The biological functions of algae and the underlying mechanisms of all these activities are included in this review. In addition, the challenges of using algae in cosmeceutical applications, such as the effectiveness of different extraction methods and processing, quality assurance, and regulations concerning extracts of algae in this sector were also discussed.

Marine natural products are a good source of antioxidants due to the presence of a wide range of bioactive compounds. Accumulating evidence proves the potential use of seaweed-derived ingredients in skincare products. This study aims to evaluate the ultraviolet (UV) protective activity of the ethanol and water extracts of Padina australis. As the preliminary attempt for this discovery, the total phenolic content (TPC) and total flavonoid content (TFC) were measured, followed by the in vitro antioxidant activity using 2,2-diphenyl-1-picrylhydrazyl (DPPH) and reducing the power to shed light on its bioactivity. The UVB protective activity was examined on HaCaT human keratinocyte cells. The findings of this study reveal that the P. australis ethanol extract serves as a promising source of antioxidants, as it exhibits stronger antioxidant activities compared with the water extract in DPPH and the reducing power assays. The P. australis ethanol extract also demonstrated a higher level of total phenolic (76 mg GAE/g) and flavonoid contents (50 mg QE/g). Meanwhile, both the ethanol (400 µg/mL) and water extracts (400 µg/mL) protected the HaCaT cells from UVB-induced cell damage via promoting cell viability. Following that, LCMS analysis reveals that the P. australis ethanol extract consists of sugar alcohol, polysaccharide, carotenoid, terpenoid and fatty acid, whereas the water extract contains compounds from phenol, terpenoid, fatty acid, fatty alcohol and fatty acid amide. In summary, biometabolites derived from P. australis have diverse functional properties, and they could be applied to the developments of cosmeceutical and pharmaceutical products.

Air pollution has recently become a subject of increasing concern in many parts of the world. The World Health Organization (WHO) estimated that nearly 4.2 million early deaths are due to exposure to fine particles in polluted air, which causes multiple respiratory diseases. Algae, as a natural product, can be an alternative treatment due to potential biofunctional properties and advantages. This systematic review aims to summarize and evaluate the evidence of metabolites derived from algae as potential anti-inflammatory agents against respiratory disorders induced by atmospheric particulate matter (PM). Databases such as Scopus, Web of Science, and PubMed were systematically searched for relevant published full articles from 2016 to 2020. The main key search terms were limited to “algae”, “anti-inflammation”, and “air pollutant”. The search activity resulted in the retrieval of a total of 36 publications. Nine publications are eligible for inclusion in this systematic review. A total of four brown algae (Ecklonia cava, Ishige okamurae, Sargassum binderi and Sargassum horneri) with phytosterol, polysaccharides and polyphenols were reported in the nine studies. The review sheds light on the pathways of particulate matter travelling into respiratory systems and causing inflammation, and on the mechanisms of actions of algae in inhibiting inflammation. Limitations and future directions are also discussed. More research is needed to investigate the potential of algae as anti-inflammatory agents against PM in in vivo and in vitro experimental models, as well as clinically.